None listed
Conditions
Interventions
None listed
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients between 20 and 80 years of age 2.A patient scheduled for regular surgery under general anesthesia in the operating room E rosette of Asan Medical Center, Seoul 3.Patients belonging to the American Society of Anesthesiology Classification 1, 2, or 3 4. Those who voluntarily agreed in writing to participate in this clinical study
Exclusion criteria
Exclusion criteria: 1. Cardiovascular disease, respiratory disease, kidney disease, endocrine disease, blood disease (hemorrhagic predisposition), central nervous system disease, mental disease, Or if there is a history of meningitis or other abnormalities (refer to laboratory test values) 2. After taking central nervous system drugs (ketamine, amphetamine, midazolam, opioid, chlorpromazine, clozapine, olanzapine, risperidone, haloperidol, quetiapine, risperidone, paliperidone, amisulpride, sertindole), the elimination half-life of each drug multiplied by 5 patient 3. Patients judged inappropriate by other researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Calculation of Approximate Entropy for EEG Changes Following Remimazolam Administration;Frequency analysis (Fourier transform and bispectral analysis) for EEG changes following remimazolam administration | — |
Secondary
| Measure | Time frame |
|---|---|
| The correlation between the bispectral index, brain anesthesia response monitoring index, and changes in the patient's level of consciousness according to the administration of remimazolam | — |
Countries
Korea, Republic of
Contacts
Public ContactJi-Yeon Bang
Asan Medical Center
Outcome results
None listed